{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T03:10:09Z","timestamp":1774321809138,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institute for Health and Care Research (NIHR) through the Royal Society for Tropical Medicine and Hygiene (RSTMH) Early Career Grants Programme","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12887-6","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:07:05Z","timestamp":1771052825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evolving profiles and treatment success predictors among tuberculosis patients in Uganda from 2019 to 2023: a registry based study"],"prefix":"10.1186","volume":"26","author":[{"given":"Collins","family":"Ankunda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jude","family":"Emunyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Namasambi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad","family":"Sserunjogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendah","family":"Kyomuhangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iving","family":"Mumbere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Nakawesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"12887_CR1","unstructured":"Tuberculosis (TB) (n.d.). Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis. Accessed 24 March 2025."},{"key":"12887_CR2","unstructured":"The End TB Strategy. (n.d.). Available: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/the-end-tb-strategy. Accessed 24 March 2025."},{"key":"12887_CR3","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1159\/000516392","volume":"100","author":"G G\u00fcnther","year":"2021","unstructured":"G\u00fcnther G, Heyckendorf J, Zellweger JP, Reimann M, Claassens M, et al. Defining outcomes of tuberculosis (Treatment): from the past to the future. Respiration. 2021;100:843\u201352.","journal-title":"Respiration"},{"key":"12887_CR4","unstructured":"WHO consolidated guidelines on tuberculosis. module 4: treatment: drug-resistant tuberculosis treatment (n.d.). Available: https:\/\/www.who.int\/publications\/i\/item\/9789240007048. Accessed 22 April 2025."},{"key":"12887_CR5","doi-asserted-by":"publisher","first-page":"e002281","DOI":"10.1136\/bmjresp-2023-002281","volume":"11","author":"V Vega","year":"2024","unstructured":"Vega V, Cabrera-Sanchez J, Rodr\u00edguez S, Verdonck K, Seas C, et al. Risk factors for pulmonary tuberculosis recurrence, relapse and reinfection: a systematic review and meta-analysis. BMJ Open Respir Res. 2024;11:e002281.","journal-title":"BMJ Open Respir Res"},{"key":"12887_CR6","doi-asserted-by":"publisher","first-page":"2100804","DOI":"10.1183\/13993003.00804-2021","volume":"58","author":"NN Linh","year":"2021","unstructured":"Linh NN, Viney K, Gegia M, Falzon D, Glaziou P, et al. World health organization treatment outcome definitions for tuberculosis: 2021 update. Eur Respir J. 2021;58:2100804.","journal-title":"Eur Respir J"},{"key":"12887_CR7","unstructured":"Mosiori K, Aminer T, Asito A. Patients characteristics associated with tuberculosis treatment default: A case control study in high incidence are in Western. Kenya Email of corresponding Authors; 2023."},{"key":"12887_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1473-3099(15)00499-5","volume":"16","author":"TA Yates","year":"2016","unstructured":"Yates TA, Khan PY, Knight GM, Taylor JG, McHugh TD, et al. The transmission of Mycobacterium tuberculosis in high burden settings. Lancet Infect Dis. 2016;16:227\u201338.","journal-title":"Lancet Infect Dis"},{"key":"12887_CR9","doi-asserted-by":"crossref","unstructured":"Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug\u2011resistant, extensively drug\u2011resistant, and incurable tuberculosis. Lancet Respir Med. 2017;5(4):291\u2013360.","DOI":"10.1016\/S2213-2600(17)30079-6"},{"key":"12887_CR10","unstructured":"Module 4. Drug-susceptible tuberculosis treatment | TB Knowledge Sharing (n.d.). Available: https:\/\/tbksp.who.int\/en\/node\/1877. Accessed 24 March 2025."},{"key":"12887_CR11","unstructured":"Consolidated guidelines for the prevention and treatment of HIV and AIDS in. Uganda, November 2022 | GPC (n.d.). Available: https:\/\/hivpreventioncoalition.unaids.org\/en\/resources\/consolidated-guidelines-prevention-and-treatment-hiv-and-aids-uganda-november-2022. Accessed 24 March 2025."},{"key":"12887_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s12879-024-09417-7","volume":"24","author":"DK Ryuk","year":"2024","unstructured":"Ryuk DK, Pelissari DM, Alves K, Oliveira PB, Castro MC, et al. Predictors of unsuccessful tuberculosis treatment outcomes in brazil: an analysis of 259,484 patient records. BMC Infect Dis. 2024;24:531.","journal-title":"BMC Infect Dis"},{"key":"12887_CR13","doi-asserted-by":"publisher","first-page":"10678","DOI":"10.3390\/ijerph182010678","volume":"18","author":"MY Teferi","year":"2021","unstructured":"Teferi MY, El-Khatib Z, Boltena MT, Andualem AT, Asamoah BO, et al. Tuberculosis treatment outcome and predictors in africa: A systematic review and Meta-Analysis. Int J Environ Res Public Health. 2021;18:10678.","journal-title":"Int J Environ Res Public Health"},{"key":"12887_CR14","unstructured":"10. Outcome definitions | TB Knowledge Sharing (n.d.). Available: https:\/\/tbksp.who.int\/en\/node\/3027#Table1.10.1. Accessed 11 September 2025."},{"key":"12887_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12890-024-03350-w","volume":"24","author":"AH Kebede","year":"2024","unstructured":"Kebede AH, Mamo H. Multidrug-resistant tuberculosis treatment outcomes and associated factors at Yirgalem general Hospital, Sidama Region, South ethiopia: a retrospective cohort study. BMC Pulm Med. 2024;24:527.","journal-title":"BMC Pulm Med"},{"key":"12887_CR16","unstructured":"WHO conducts mid-term review of Uganda\u2019s response to TB | WHO | Regional Office for Africa. (2023). Available: https:\/\/www.afro.who.int\/countries\/uganda\/news\/who-conducts-mid-term-review-ugandas-response-tb. Accessed 11 September 2025."},{"key":"12887_CR17","unstructured":"The Hospital | Mildmay Uganda (n.d.). Available: https:\/\/mildmay.or.ug\/hospital. Accessed 8 August 2023."},{"key":"12887_CR18","unstructured":"National Strategic Plan For Tuberculosis and Leprosy. Control 2020\/21\u20132024\/25 | MOH Knowledge Management Portal (n.d.). Available: https:\/\/library.health.go.ug\/communicable-disease\/tuberculosis\/national-strategic-plan-tuberculosis-and-leprosy-control-202021. Accessed 24 March 2025."},{"key":"12887_CR19","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.3390\/ijerph20053825","volume":"20","author":"E Olmastroni","year":"2023","unstructured":"Olmastroni E, Galimberti F, Tragni E, Catapano AL, Casula M. Impact of COVID-19 pandemic on adherence to chronic therapies: A systematic review. Int J Environ Res Public Health. 2023;20:3825.","journal-title":"Int J Environ Res Public Health"},{"key":"12887_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3390\/healthcare11040501","volume":"11","author":"CR Kalaman","year":"2023","unstructured":"Kalaman CR, Ibrahim N, Shaker V, Cham CQ, Ho MC, et al. Parental factors associated with child or adolescent medication adherence: A systematic review. Healthcare. 2023;11:501.","journal-title":"Healthcare"},{"key":"12887_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.yfpn.2022.11.004","volume":"5","author":"D Gray-Miceli","year":"2023","unstructured":"Gray-Miceli D, Gray K, Sorenson MR, Holtzclaw BJ. Immunosenescence and infectious disease risk among aging adults. Adv Fam Pract Nurs. 2023;5:27\u201340.","journal-title":"Adv Fam Pract Nurs"},{"key":"12887_CR22","doi-asserted-by":"publisher","first-page":"1146704","DOI":"10.3389\/fimmu.2023.1146704","volume":"14","author":"A Grifoni","year":"2023","unstructured":"Grifoni A, Alonzi T, Alter G, Noonan DM, Landay AL, et al. Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis. Front Immunol. 2023;14:1146704.","journal-title":"Front Immunol"},{"key":"12887_CR23","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3390\/pathogens11101101","volume":"11","author":"AM Olmo-Font\u00e1nez","year":"2022","unstructured":"Olmo-Font\u00e1nez AM, Turner J. Tuberculosis in an aging world. Pathogens. 2022;11:1101.","journal-title":"Pathogens"},{"key":"12887_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/s12879-020-05354-3","volume":"20","author":"X Chen","year":"2020","unstructured":"Chen X, Du L, Wu R, Xu J, Ji H, et al. The effects of family, society and National policy support on treatment adherence among newly diagnosed tuberculosis patients: a cross-sectional study. BMC Infect Dis. 2020;20:623.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 1","key":"12887_CR25","first-page":"S105","volume":"11","author":"E Namukwaya","year":"2011","unstructured":"Namukwaya E, Nakwagala FN, Mulekya F, Mayanja-Kizza H, Mugerwa R. Predictors of treatment failure among pulmonary tuberculosis patients in Mulago hospital, Uganda. Afr Health Sci. 2011;11(Suppl 1):S105\u2013111.","journal-title":"Afr Health Sci"},{"key":"12887_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijid.2022.04.031","volume":"120","author":"HE Jenkins","year":"2022","unstructured":"Jenkins HE, Ayuk S, Puma D, Brooks MB, Millones AK, et al. Geographic accessibility to health facilities predicts uptake of community-based tuberculosis screening in an urban setting. Int J Infect Dis. 2022;120:125\u201331.","journal-title":"Int J Infect Dis"},{"key":"12887_CR27","doi-asserted-by":"publisher","first-page":"e0227293","DOI":"10.1371\/journal.pone.0227293","volume":"15","author":"SB Marahatta","year":"2020","unstructured":"Marahatta SB, Yadav RK, Giri D, Lama S, Rijal KR, et al. Barriers in the access, diagnosis and treatment completion for tuberculosis patients in central and Western nepal: A qualitative study among patients, community members and health care workers. PLoS ONE. 2020;15:e0227293.","journal-title":"PLoS ONE"},{"key":"12887_CR28","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/COH.0000000000000579","volume":"14","author":"BA Bunda","year":"2019","unstructured":"Bunda BA, Bassett IV. Reaching the second 90: the strategies for linkage to care and antiretroviral therapy initiation. Curr Opin HIV AIDS. 2019;14:494\u2013502.","journal-title":"Curr Opin HIV AIDS"},{"key":"12887_CR29","unstructured":"Electronic recording and reporting for tuberculosis care. and control (n.d.). Available: https:\/\/www.who.int\/publications\/i\/item\/9789241564465. Accessed 24 March 2025."},{"key":"12887_CR30","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1093\/jpids\/piac070","volume":"11","author":"JI Campbell","year":"2022","unstructured":"Campbell JI, Menzies D. Testing and scaling interventions to improve TB infection care cascade. J Pediatr Infect Dis Soc. 2022;11:S94\u2013100.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"12887_CR31","doi-asserted-by":"publisher","first-page":"107196","DOI":"10.1016\/j.ijid.2024.107196","volume":"147","author":"H Chen","year":"2024","unstructured":"Chen H, Zhang H, Cheng J, Sun D, Wang Q, et al. Adherence to preventive treatment for latent tuberculosis infection in close contacts of pulmonary tuberculosis patients: A cluster-randomized controlled trial in China. Int J Infect Dis. 2024;147:107196.","journal-title":"Int J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12887-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12887-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12887-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:42:41Z","timestamp":1774280561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12887-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12887"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12887-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the Mildmay Uganda Research Ethics Committee (#REC REF 0201\u20132024) and the Uganda National Council for Science and Technology (HS3873ES). A waiver of informed consent was granted by Mildmay Uganda Research Ethics Committee for the use of de-identified retrospective data. Administrative clearance was sought from MUgH administration to access participant data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A waiver was granted for publication de-identified retrospective data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"597"}}